Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
DNK
company
About
DNK engages in R&D, production, clinical application and technical service of invasive fungal disease diagnosis.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥10M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Mar 10, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥13M
DNK has raised a total of
¥13M
in funding over 2 rounds. Their latest funding was raised on
Nov 19, 2015 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 19, 2015 | Series A | ¥10M | 1 | — | — | Detail |
| Dec 31, 2014 | Angel | ¥3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
DNK is funded by 2 investors.
Teke Touzi
and Sunz Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Sunz Fund
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
